FDA approves Alzheimer’s drug that slowed cognitive decline in clinical trial
MRI image of brain showing area of Alzheimer patient. Getty Images The Food and Drug Administration on Friday granted accelerated approval for the Alzheimer’s drug lecanemab, the second treatment from […]